Postoperative nausea and vomiting after general anesthesia with Remimazolam.

JRCT ID: jRCT1041210079

Registered date:05/10/2021

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: General anesthesia
• Date of first enrollment: 05/10/2021
• Target sample size: 5000
• Study type: Observational

Outcome(s)

• Primary Outcome: incidence of postoperative nausea and vomiting

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both
• Include criteria: All patients who had undergone surgery under general anesthesia at Hamamatsu University Hospital since August 2020.
• Exclude criteria: less than 20 years of age, incorrect enrollment other than general anesthesia, postoperative artificial respiration, cancellation of surgery after induction of anesthesia, lack of consciousness after anesthesia, reoperation within 24 hours after anesthesia, insufficient data due to follow-up shorter than 24 hours, and maintenance with a combination of propofol and remimazolam.

Related Information

• Primary Sponsor: Suzuki Yuji